Bernadette Fitzgibbon

Bernadette Fitzgibbon is an Associate Professor at the Australian National University School of Medicine and Psychology. She serves as Director of Psychiatry Research at Paratus Clinical and previously held leadership roles in the Australian Brain Alliance EMCR Network (2017-2021) and Australasian Brain Stimulation Society (2019-2023). Her work bridges clinical neuroscience, mental health, and neuromodulation therapies.

• Research Focus: Pain neuroscience, brain stimulation (TMS, tDCS), meditation effects, and psychedelic-assisted psychotherapy
• Collaborations: Engages with consumers, policymakers, and international research teams in multi-site clinical trials

Her research program emphasizes interdisciplinary approaches to mental health and pain management, with publications spanning clinical trials, neuroimaging, and machine learning-based pain classification. Key trends show integration of neuromodulation with psychosocial factors and AI applications in healthcare.

Scientific Awards:

• 2021 Tess Cramond Lecture (Australasian Pain Society)
• 2018 Australasian Brain Stimulation Society Early Career Award
• Plenary speaker at 2022 & 2024 Neuromodulation Society meetings

She has secured >5 million in research funding and published over 80 articles, including systematic reviews on psilocybin safety, opioidergic mechanisms, and functional connectivity in psychiatric disorders. Her work on meditation and brain-heart interactions highlights novel psychophysiological pathways.